Hardy Speaks at Panel on Marijuana Regulation and Taxation Act
July 22, 2021 | Cannabis | Employment & Labor
On July 21, 2021, Tamika Hardy spoke at the Employment & NY Marijuana Legalization (MRTA) panel, presented by the Brooklyn branch of the NAACP. The Brooklyn NAACP’s Justice Reform and Legal Redress Committees discussed the New York legalization of cannabis as it relates to employment. Hardy discussed what recreational cannabis legalization means in the employment …
Read More
Shapiro Quoted on CBD Warning Letters in Vitamin Retailer
March 29, 2021 | Cannabis | Compliance Investigations & White Collar
Steven Shapiro was quoted in the Vitamin Retailer article, “FDA Warns Selling of Topical CBD Products Violates FD&C Act.” The FDA has issued warning letters to two companies addressing the illegal marketing of unapproved drugs labeled as containing CBD. Shapiro questions the letters as neither discussed the potential to use CBD as an inactive ingredient …
Read More
Ullman Speaks at Natural Products Insider Webinar
October 6, 2020 | Cannabis
On September 30, Marc Ullman spoke at the Natural Products Insider webinar “Hemp Evolution: Surviving the imminent regulatory shockwave.” The presentation discussed mitigating legal risks and thriving in the multi-billion dollar hemp phytocannabinoid market. The video is still available to view. Click here to register and watch. …
Read More
Ullman Speaks with NutraIngredients-USA
August 26, 2020 | Cannabis | Health Services
Marc Ullman was quoted in a NutraIngredients-USA article, “AHPA event aims to guide CBD industry.” The article discusses how products containing cannabidiol (CBD) represent a rapidly growing yet uncertain market segment, with those in the industry often finding themselves with more questions than answers. Click here to read the full article. …
Read More
Ullman Quoted in NutraIngredients USA
August 21, 2020 | Cannabis | Health Services
Marc Ullman was quoted in a NutraIngredients USA article, “Upcoming event aims to help fill regulatory holes in hemp/CBD industry.” The article discusses how CBD firms are often unprepared for the regulatory compliance side of operating a dietary supplement firm. The upcoming event that is being discussed in the article looks to assist with that. …
Read More
Ullman to Present at Virtual Hemp-CBD Supplement Congress
July 20, 2020 | Cannabis | Health Services | Compliance Investigations & White Collar
On August 27, Marc Ullman will be presenting at the American Herbal Products Association (AHPA) Hemp-CBD Supplement Virtual Congress. The seminar will provide companies with an understanding of federal and state legal and regulatory obligations and current issues and opportunities in the hemp-CBD market. Click here to register. …
Read More
Ullman Cited in Article on CBD in Foods and Beverages
June 15, 2020 | Cannabis | Health Services
Marc Ullman was cited in Nutritional Outlook’s article, “High anxiety: Will CBD ever be legal in foods and beverages?” The article discusses whether or not the FDA will ever approve the use of CBD in foods and beverages. Currently, it is not a lawful ingredient. Ullman provided advice on the procedures necessary to prove the …
Read More
Ullman Lends Perspective on FDA Warning Letter
June 4, 2020 | Cannabis | Compliance Investigations & White Collar
Marc Ullman was quoted in a article entitled “Warning letter cites CBD’s regulatory status as leading issue.” The Food and Drug Administration sent a warning letter to a supplement manufacturer regarding various failures in good manufacturing practice (GMP). For the first time, however, the letter cited the health claims made about CBD as the first …
Read More
Shapiro Speaks to NYSBA Food, Drug and Cosmetic Law Section
January 29, 2020 | Cannabis | Compliance Investigations & White Collar
On Thursday, January 30, 2020, Steven Shapiro will present to the New York State Bar Association’s Food, Drug and Cosmetic Law Section as part of its Off-Label Promotion Update. His presentation is entitled “Promotion of CBD following Epidiolex for Rx, OTC drugs and other products. For information and to register, click here. …
Read More
Ullman’s Op-Ed on CBD Appears in Long Island Business News
| Compliance Investigations & White Collar | Cannabis
On January 29, 2020, Marc Ullman’s opinion piece, “FDA’s lack of CBD guidance is a disservice to Long Island firms,” appeared in Long Island Business News. Marc notes that an exploding market for CBD products has created a conundrum for companies wishing to cash in. Either they obey FDA’s regulations and lose out, or they break …
Read More
Next Page

Get legal updates and news delivered to your inbox